Company / Free Cash Flow per Share
Ernexa Therapeutics Inc. Free Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4.73
FY2025
5-year range
-$4.73 / $0.61
FY2021-FY2025
Trend
-25.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.73 in FY2025 to $0.61 in FY2020.
Based on SEC 10-K filings.
-4.73 in FY2025.
Declined from $-4.15 to $-4.73 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 25.3% year-over-year.
- Peak free cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.73 | -25.3% |
| FY2024 | -$3.78 | +9.0% |
| FY2023 | -$4.15 | -777.0% |
| FY2020 | $0.61 | +145.8% |
| FY2019 | $0.25 | +451.2% |
| FY2018 | -$0.07 | -1524.6% |
| FY2017 | -$0.00 | +99.8% |
| FY2016 | -$2.80 | -3477.9% |
| FY2015 | -$0.08 | -1072.7% |
| FY2014 | $0.01 | -38.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026